Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Definitive Healthcare (DH) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • Definitive Healthcare's Share-based Compensation rose 616.26% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year decrease of 3553.46%. This contributed to the annual value of $38.1 million for FY2024, which is 2185.93% down from last year.
  • According to the latest figures from Q3 2025, Definitive Healthcare's Share-based Compensation is $6.7 million, which was up 616.26% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Definitive Healthcare's Share-based Compensation ranged from a high of $15.6 million in Q1 2024 and a low of $406000.0 during Q1 2021
  • For the 5-year period, Definitive Healthcare's Share-based Compensation averaged around $8.1 million, with its median value being $7.4 million (2024).
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 159261.08% in 2022, then crashed by 5302.91% in 2025.
  • Quarter analysis of 5 years shows Definitive Healthcare's Share-based Compensation stood at $5.6 million in 2021, then skyrocketed by 103.31% to $11.4 million in 2022, then increased by 16.02% to $13.3 million in 2023, then crashed by 44.43% to $7.4 million in 2024, then fell by 9.25% to $6.7 million in 2025.
  • Its last three reported values are $6.7 million in Q3 2025, $7.0 million for Q2 2025, and $7.3 million during Q1 2025.